MF59 adjuvant-mediated innate immune activation (MF59)

MF59 is a proprietary squalene-based oil-in-water emulsion adjuvant used mainly in influenza vaccines. It acts primarily by creating a highly immunocompetent microenvironment at the injection site, rapidly recruiting and activating innate immune cells and facilitating the uptake and presentation of co-administered antigens by APCs[3][1][4]. MF59 triggers innate immune activation via the release of DAMPs (such as ATP) from muscle cells and the consequent release of chemokines and cytokines, recruiting more immune cells to the site, and indirectly promoting robust, high-quality humoral and cellular immune responses[1][2][3][4]. While MF59 does not act through direct engagement of specific pattern recognition receptors like TLRs, it does require MyD88 and ASC pathway activation for its adjuvant effects[1][2][4]. Its effect is most accurately described as adjuvant-induced immunological modulation rather than activity at a defined molecular target.\n\nNote: MF59 (and specifically MF59C.1) is an adjuvant formulation, not a molecule, receptor, enzyme, or traditional drug target. The phrase "Innate immune activation via MF59C.1 adjuvant" describes a process, not a molecular target. If structured data for drug targets is needed, MF59-related responses should be annotated under adjuvant mechanism of action, not as a discrete molecular entity[3][4][1][2].

Other names

MF59MF59C.1Squalene emulsion adjuvant

Formation of an immunocompetent microenvironment at the injection site, leading to chemokine and cytokine production and recruitment of immune cells[3][1][4]; Enhancement of antigen uptake and presentation by antigen-presenting cells (APCs), leading to stronger T and B cell activation[3][1][4]; Induction of damage-associated molecular patterns (DAMPs), such as ATP release, which stimulate pattern recognition receptors (PRRs), though exact PRRs remain undefined[1][4]; ASC/inflammasome (NLRP3-independent) and MyD88-dependent pathways are involved, but MF59 does not directly stimulate TLRs[1][2][4]; Promotion of mixed Th1/Th2 immune responses[2][4]; Stimulation of follicular helper T cells and germinal center formation for high-quality antibody responses[1][2]